Get an alert when BIORELIANCE LTD. files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-02-23 (in 9mo)

Last made up 2026-02-09

Watchouts

None on the register

Cash

£735K

-30.7% vs 2023

Net assets

£124M

+9.7% vs 2023

Employees

767

+1.7% vs 2023

Profit before tax

£53M

+12% vs 2023

Name history

Renamed 2 times since incorporation

  1. BIORELIANCE LTD. 1997-07-04 → present
  2. MICROBIOLOGICAL ASSOCIATES LTD. 1993-10-28 → 1997-07-04
  3. MICROBIOLOGICAL ASSOCIATES INTERNATIONAL, LTD. 1990-02-09 → 1993-10-28

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £163,872,000£173,251,000
Operating profit £42,841,000£48,766,000
Profit before tax £47,218,000£52,872,000
Net profit £36,776,000£40,013,000
Cash £1,061,000£735,000
Total assets less current liabilities £117,257,000£128,311,000
Net assets £112,640,000£123,524,000
Equity £112,640,000£123,524,000
Average employees 754767
Wages £30,439,000£33,552,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 26.1%28.1%
Net margin 22.4%23.1%
Return on capital employed 36.5%38.0%
Current ratio 6.24x7.13x
Interest cover 1338.78x207.51x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Deloitte LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors have prepared cash flow forecasts for a period covering at least 12 months from the date of signing of these financial statements which indicate that, taking account of reasonably possible downsides, the Company will have sufficient funds through its central cash pooling account to meet its liabilities as they fall due for that period. In preparing those forecasts they have considered a reasonably possible downside scenario in which the average margin for the past three years has been used where this is below the margin achieved for the last twelve months. The Directors also note that the Company has positive net current assets and net assets position as at the balance sheet date.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 34 resigned

Name Role Appointed Born Nationality
A G SECRETARIAL LIMITED Corporate Secretary 2016-05-01
ARMSTRONG, Alison Ann Director 2024-03-31 Aug 1964 British
MASSEY, Alison Eve Director 2023-03-01 Sep 1964 British
Show 34 resigned officers
Name Role Appointed Resigned
BEGG, John Alexander Secretary 2007-04-30 2016-01-05
HARWOOD JR, Charles Cumings Secretary 2007-04-12 2007-04-30
MACLEOD, Genoffir Maud Secretary 2006-05-08 2007-04-12
MILLER, George Lloyd Secretary 2012-01-31 2015-11-18
ORR, William Robert Secretary 1993-09-16 2006-05-08
BONAR MCKENZIE WS Corporate Secretary 1993-09-16
BEGG, John Alexander Director 2014-07-01 2016-01-05
BIRO, Peter Director 2017-07-01 2023-03-01
BROWN, James, Dr Director 1992-10-28
BRUST, Bernd Director 2006-05-05 2007-04-12
BURGSTAHLER, David Frederick Director 2007-09-21 2007-10-25
COSGROVE, Raymond Francis, Dr Director 1993-02-22 2005-08-22
COTTIER, Gilles Director 2012-01-31 2015-11-18
CULLEN, Archibald Francis Skinnider Director 2012-01-31 2017-09-15
DARLING, Allan James, Dr Director 2005-04-05 2006-05-05
DERRINGTON, Stephen Timothy Director 2007-04-12 2007-10-25
DODD, David Alan Director 2007-12-21 2009-04-22
HAMILTON, Victoria Director 1990-02-15 1993-02-28
HARWOOD JR, Charles Cumings Director 2009-04-22 2013-03-31
JONES, Mark Anthony Director 2014-07-01 2016-05-31
KRATZER, Stefan Director 2016-07-25 2017-07-01
LUCAS, Graham Director 2012-01-31 2014-07-01
MCCLELLAND, David Hannah Director 2017-09-15 2024-03-31
MCDONALD, Capers Walter Director 1993-02-22 2004-06-10
SCHWAN, Carl Christian Director 1993-09-16 1998-10-09
SHUDTER, Lewis John Director 1990-04-02 1993-02-22
SMITH, David Harper Director 2004-08-16 2007-04-12
SOUTER, Thomas Ireland Director 2006-05-05 2007-04-12
SPRATT, Patrick Director 1999-10-08 2000-01-04
THEODORE, Philip Allen Director 2008-12-19 2009-04-22
VENABLES, David Charles, Dr Director 2006-05-05 2007-04-12
WALKER, David Steven Director 2007-09-21 2012-05-11
WHELAN, Douglas Francis Director 1990-02-15 1993-09-16
WISHER, Martin Director 1990-04-02 2003-09-23

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Merck Kgaa Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2022-12-06 Active
Bioreliance Uk Acquisition Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Ceased 2022-12-06

Filing timeline

Last 20 of 192 total filings

Date Type Category Description
2026-03-04 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-06-23 AA accounts Accounts with accounts type full
2025-02-10 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-08-30 AA accounts Accounts with accounts type full
2024-04-11 AP01 officers Appoint person director company with name date PDF
2024-04-11 TM01 officers Termination director company with name termination date PDF
2024-02-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-01-10 PSC02 persons-with-significant-control Notification of a person with significant control PDF
2024-01-10 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2023-07-12 AA accounts Accounts with accounts type full
2023-03-01 AP01 officers Appoint person director company with name date PDF
2023-03-01 TM01 officers Termination director company with name termination date PDF
2023-02-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-10-06 AA accounts Accounts with accounts type full
2022-02-25 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-06-25 AA accounts Accounts with accounts type full
2021-02-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-12-01 AA accounts Accounts with accounts type full
2020-02-14 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-02-03 PSC05 persons-with-significant-control Change to a person with significant control PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page